olpasiran
Jump to navigation
Jump to search
Mechanism of action
- reduces lipoprotein(a) synthesis in the liver[1]
More general terms
References
- ↑ 1.0 1.1 O'Donoghue ML, Rosenson RS, Gencer B et al Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease. N Engl J Med. 2022. Nov 6 PMID: https://www.ncbi.nlm.nih.gov/pubmed/36342163 https://www.nejm.org/doi/full/10.1056/NEJMoa2211023